How Do Pravastatin and Lipitor Compare?
Pravastatin (Pravachol) and atorvastatin (Lipitor) are both statins that lower LDL cholesterol and reduce cardiovascular risk by inhibiting HMG-CoA reductase. Atorvastatin is more potent, achieving greater LDL reductions at equivalent doses—20mg atorvastatin matches about 40mg pravastatin.[1] Both carry black-box warnings for muscle damage (rhabdomyolysis) and liver enzyme elevation, but pravastatin has a lower risk of drug interactions due to minimal CYP3A4 metabolism.
Can You Switch from Lipitor to Pravastatin?
Yes, physicians often substitute pravastatin for atorvastatin, especially for cost savings or intolerance. Pravastatin is fully generic since 2010, while atorvastatin's main patents expired in 2011 (U.S. Patent No. 5,273,995), making it generic too, but pravastatin remains cheaper (often $10-20/month vs. $20-50 for generic atorvastatin).[2] Monitor lipids 4-6 weeks post-switch, as efficacy varies; some patients need dose adjustments.
When Does Lipitor's Patent Expire Fully?
Lipitor's core composition patent expired November 2011, enabling generics worldwide. Pediatric exclusivity extended U.S. market exclusivity to November 30, 2011. Remaining process patents (e.g., U.S. Patent No. 6,126,971, expired 2017) faced challenges but no longer block generics.[3] Check DrugPatentWatch.com for latest litigation or evergreening attempts.
What Are Common Reasons to Choose Pravastatin Over Lipitor?
- Lower interaction risk: Pravastatin avoids issues with grapefruit juice or drugs like erythromycin that affect atorvastatin.[1]
- Renal safety: Preferred in mild kidney impairment; both dose-adjusted for severe cases.
- Pregnancy: Pravastatin has more safety data (Category B vs. X for atorvastatin).
Patients report fewer muscle aches with pravastatin in some studies, though individual responses differ.[4]
Effectiveness and Side Effect Differences
| Aspect | Pravastatin | Atorvastatin (Lipitor) |
|--------|-------------|------------------------|
| LDL Reduction (40mg dose) | 30-35% | 45-50% |
| HDL Increase | 5-10% | 5-15% |
| Half-Life | 1.5-2 hours | 14 hours |
| Common Sides | Headache, nausea (similar rates) | Slightly higher diabetes risk (1-2% absolute) |
Real-world data from trials like PROVE-IT show atorvastatin edges out pravastatin for event reduction, but both cut risk 20-30% vs. placebo.[5] Diabetes risk is dose-dependent for all statins.
Cost and Availability Today
Generic pravastatin: $4-15 for 30-day supply at major pharmacies. Generic atorvastatin: $5-25. No branded Lipitor since 2011; Pfizer earns from authorized generics elsewhere.
[1]: FDA Labels: Pravachol, Lipitor
[2]: GoodRx Pricing
[3]: DrugPatentWatch: Lipitor
[4]: JAMA: Statin Comparisons
[5]: NEJM: PROVE-IT Trial